Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q4 2018 13F Holders as of 31 Dec 2018
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 16,786,897
- Total 13F value
- $503,433,000
- Share change
- +621,995
- SEC-reported price per share
- $29.99
- Number of holders
- 50
- Value change
- +$19,006,654
- Number of buys
- 27
- Number of sells
- 20
- Shares outstanding
- 105,000,216
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2018
Institutions
50
Top holders
10
CRNX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2019
Previous quarter: Q3 2018
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Ownership snapshot
Top reported holders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2018
13F
Lead comparable stake: 3.6%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Vivo Capital, LLC
3.6%
FMR LLC
2.6%
PERCEPTIVE ADVISORS LLC
2.5%
ORBIMED ADVISORS LLC
1.8%
RA CAPITAL MANAGEMENT, L.P.
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
3.6%
|
$108,646,000
3,792,169 shares
|
— | 30 Sep 2018 |
| FMR LLC |
13F
Company
|
2.6%
|
$77,866,000
2,717,838 shares
|
— | 30 Sep 2018 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2.5%
|
$74,144,000
2,587,953 shares
|
— | 30 Sep 2018 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.8%
|
$54,844,000
1,914,282 shares
|
— | 30 Sep 2018 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.6%
|
$48,734,000
1,701,017 shares
|
— | 30 Sep 2018 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
0.5%
|
$15,034,000
524,744 shares
|
— | 30 Sep 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
50
Shares
16,786,897
Rows available
50
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
49
Q4 2018 holders
50
Holder diff
1
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 value | Q4 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend